BR9709234A - Composto com atividades antiinflamatórias e imunossupressivas - Google Patents

Composto com atividades antiinflamatórias e imunossupressivas

Info

Publication number
BR9709234A
BR9709234A BR9709234A BR9709234A BR9709234A BR 9709234 A BR9709234 A BR 9709234A BR 9709234 A BR9709234 A BR 9709234A BR 9709234 A BR9709234 A BR 9709234A BR 9709234 A BR9709234 A BR 9709234A
Authority
BR
Brazil
Prior art keywords
inflammatory
immunosuppressive activities
immunosuppressive
activities
Prior art date
Application number
BR9709234A
Other languages
English (en)
Other versions
BR9709234B1 (pt
BR9709234B8 (pt
Inventor
Giorgio Bertolini
Mauro Biffi
Flavio Leoni
Jacques Mizrahi
Gianfranco Pavich
Paolo Mascagni
Original Assignee
Italfarmaco Spa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=11374259&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=BR9709234(A) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Italfarmaco Spa filed Critical Italfarmaco Spa
Publication of BR9709234A publication Critical patent/BR9709234A/pt
Publication of BR9709234B1 publication Critical patent/BR9709234B1/pt
Publication of BR9709234B8 publication Critical patent/BR9709234B8/pt

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C259/00Compounds containing carboxyl groups, an oxygen atom of a carboxyl group being replaced by a nitrogen atom, this nitrogen atom being further bound to an oxygen atom and not being part of nitro or nitroso groups
    • C07C259/04Compounds containing carboxyl groups, an oxygen atom of a carboxyl group being replaced by a nitrogen atom, this nitrogen atom being further bound to an oxygen atom and not being part of nitro or nitroso groups without replacement of the other oxygen atom of the carboxyl group, e.g. hydroxamic acids
    • C07C259/10Compounds containing carboxyl groups, an oxygen atom of a carboxyl group being replaced by a nitrogen atom, this nitrogen atom being further bound to an oxygen atom and not being part of nitro or nitroso groups without replacement of the other oxygen atom of the carboxyl group, e.g. hydroxamic acids having carbon atoms of hydroxamic groups bound to carbon atoms of six-membered aromatic rings
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00Drugs for immunological or allergic disorders
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00Drugs for immunological or allergic disorders
    • A61P37/02Immunomodulators
    • A61P37/06Immunosuppressants, e.g. drugs for graft rejection
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C275/00Derivatives of urea, i.e. compounds containing any of the groups, the nitrogen atoms not being part of nitro or nitroso groups
    • C07C275/28Derivatives of urea, i.e. compounds containing any of the groups, the nitrogen atoms not being part of nitro or nitroso groups having nitrogen atoms of urea groups bound to carbon atoms of six-membered aromatic rings of a carbon skeleton
    • C07C275/42Derivatives of urea, i.e. compounds containing any of the groups, the nitrogen atoms not being part of nitro or nitroso groups having nitrogen atoms of urea groups bound to carbon atoms of six-membered aromatic rings of a carbon skeleton being further substituted by carboxyl groups
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D217/00Heterocyclic compounds containing isoquinoline or hydrogenated isoquinoline ring systems
    • C07D217/12Heterocyclic compounds containing isoquinoline or hydrogenated isoquinoline ring systems with radicals, substituted by hetero atoms, attached to carbon atoms of the nitrogen-containing ring
    • C07D217/14Heterocyclic compounds containing isoquinoline or hydrogenated isoquinoline ring systems with radicals, substituted by hetero atoms, attached to carbon atoms of the nitrogen-containing ring other than aralkyl radicals
    • C07D217/16Heterocyclic compounds containing isoquinoline or hydrogenated isoquinoline ring systems with radicals, substituted by hetero atoms, attached to carbon atoms of the nitrogen-containing ring other than aralkyl radicals substituted by oxygen atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C2602/00Systems containing two condensed rings
    • C07C2602/02Systems containing two condensed rings the rings having only two atoms in common
    • C07C2602/04One of the condensed rings being a six-membered aromatic ring
    • C07C2602/10One of the condensed rings being a six-membered aromatic ring the other ring being six-membered, e.g. tetraline
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C2603/00Systems containing at least three condensed rings
    • C07C2603/02Ortho- or ortho- and peri-condensed systems
    • C07C2603/04Ortho- or ortho- and peri-condensed systems containing three rings
    • C07C2603/06Ortho- or ortho- and peri-condensed systems containing three rings containing at least one ring with less than six ring members
    • C07C2603/10Ortho- or ortho- and peri-condensed systems containing three rings containing at least one ring with less than six ring members containing five-membered rings
    • C07C2603/12Ortho- or ortho- and peri-condensed systems containing three rings containing at least one ring with less than six ring members containing five-membered rings only one five-membered ring
    • C07C2603/18Fluorenes; Hydrogenated fluorenes
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C2603/00Systems containing at least three condensed rings
    • C07C2603/56Ring systems containing bridged rings
    • C07C2603/58Ring systems containing bridged rings containing three rings
    • C07C2603/70Ring systems containing bridged rings containing three rings containing only six-membered rings
    • C07C2603/74Adamantanes

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Engineering & Computer Science (AREA)
  • Public Health (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Immunology (AREA)
  • Transplantation (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Plant Substances (AREA)
BRPI9709234-7B8A 1996-05-14 1997-05-12 Composto com atividades antiinflamatórias e imunossupressivas. BR9709234B8 (pt)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
IT96MI000968A IT1283637B1 (it) 1996-05-14 1996-05-14 Composti ad attivita' antinfiammatoria ed immunosoppressiva
PCT/EP1997/002407 WO1997043251A1 (en) 1996-05-14 1997-05-12 Compounds with anti-inflammatory and immunosuppressive activities

Publications (3)

Publication Number Publication Date
BR9709234A true BR9709234A (pt) 1999-08-10
BR9709234B1 BR9709234B1 (pt) 2009-01-13
BR9709234B8 BR9709234B8 (pt) 2014-04-15

Family

ID=11374259

Family Applications (1)

Application Number Title Priority Date Filing Date
BRPI9709234-7B8A BR9709234B8 (pt) 1996-05-14 1997-05-12 Composto com atividades antiinflamatórias e imunossupressivas.

Country Status (19)

Country Link
US (1) US6034096A (pt)
EP (1) EP0901465B1 (pt)
JP (1) JP4108127B2 (pt)
CN (1) CN1105100C (pt)
AU (1) AU713300B2 (pt)
BR (1) BR9709234B8 (pt)
CA (1) CA2254066C (pt)
CZ (1) CZ293233B6 (pt)
DE (1) DE69703207T2 (pt)
DK (1) DK0901465T3 (pt)
ES (1) ES2151267T3 (pt)
GR (1) GR3035128T3 (pt)
HU (2) HUP9902818A3 (pt)
IT (1) IT1283637B1 (pt)
PL (1) PL187527B1 (pt)
PT (1) PT901465E (pt)
RU (1) RU2177473C2 (pt)
SK (1) SK282174B6 (pt)
WO (1) WO1997043251A1 (pt)

Families Citing this family (28)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2352740A1 (en) 1998-12-10 2000-06-15 F. Hoffmann-La Roche Ag Procollagen c-proteinase inhibitors
EP1149079B1 (en) * 1999-02-04 2004-04-21 SK Corporation Tetrahydro isoquino linealkanol derivatives and pharmaceutical compositions containing same
AU3631500A (en) 1999-03-19 2000-10-09 Du Pont Pharmaceuticals Company N-adamant-1-yl-n'-(4-chlorobenzothiazol-2-yl) urea useful in the treatment of inflammation and as an anticancer radiosensitizing agent
DE60143098D1 (de) 2000-05-31 2010-10-28 Santen Pharmaceutical Co Ltd (Pyridinyl)alkyl-Amide oder -Harnstoffe als TNF-alpha Bildung Inhibitoren
JP2004509941A (ja) * 2000-09-29 2004-04-02 プロリフィクス リミテッド Hdacインヒビターとしてのアミド結合を含むカルバミン酸化合物
ITMI20011733A1 (it) * 2001-08-07 2003-02-07 Italfarmaco Spa Derivati dell'acido idrossamico inibitori degli enzimi istone deacetilasi, quali nuovi farmaci antiinfiammatori inibenti la sintesi di citoc
PE20030701A1 (es) 2001-12-20 2003-08-21 Schering Corp Compuestos para el tratamiento de trastornos inflamatorios
WO2003070691A1 (fr) * 2002-02-21 2003-08-28 Osaka Industrial Promotion Organization Derive de n-hydroxycarboxamide
ITMI20030025A1 (it) 2003-01-10 2004-07-11 Italfarmaco Spa Derivati dell'acido idrossammico ad attivita' antinfiammatoria.
ITMI20030063A1 (it) * 2003-01-17 2004-07-18 Italfarmaco Spa Cloridrato monoidrato dell'estere (6-dietilamminometil-naftalen-2-il)metilico dell'acido (4-idrossicarbammoil-fenil)carbammico.
ITMI20030064A1 (it) * 2003-01-17 2004-07-18 Italfarmaco Spa Uso dei derivati dell'acido idrossamico per la preparazione
US7291744B2 (en) 2003-11-13 2007-11-06 Bristol-Myers Squibb Company N-ureidoalkyl-amino compounds as modulators of chemokine receptor activity
US9115090B2 (en) * 2003-12-02 2015-08-25 The Ohio State University Research Foundation Zn2+-chelating motif-tethered short-chain fatty acids as a novel class of histone deacetylase inhibitors
WO2006115509A2 (en) 2004-06-24 2006-11-02 Novartis Vaccines And Diagnostics Inc. Small molecule immunopotentiators and assays for their detection
ITMI20041347A1 (it) * 2004-07-05 2004-10-05 Italfarmaco Spa Derivati di alfa-amminoacidi ad attivita'antiinfiammatoria
US20100152188A1 (en) * 2005-08-05 2010-06-17 Akella Satya Surya Visweswara Srinivas Novel Heterocyclic Compounds
IT1392908B1 (it) 2008-09-29 2012-04-02 Italfarmaco Spa Uso degli inibitori delle istone-deacetilasi per la cura di sindromi mieloproliferative philadelphia-negative
AU2009305214B2 (en) * 2008-10-15 2015-06-25 Generics [Uk] Limited Process for the preparation of vorinostat
US8754129B2 (en) 2008-11-26 2014-06-17 Generics [Uk] Limited Crystalline vorinostat form VI
KR101168801B1 (ko) 2009-03-27 2012-07-25 주식회사종근당 신규한 하이드록사메이트 유도체, 이의 제조방법, 및 이를 함유하는 약제학적 조성물
IT1396915B1 (it) 2009-10-23 2012-12-20 Italfarmaco Spa Dietil-[6-(4-idrossicarbamoil-fenil-carbamoilossimetil)-naftalen-2-il-metil]-ammonio cloruro ed altri derivati della n-idrossi-benzammide per l'uso nel trattamento di infezioni da hiv.
IT1397912B1 (it) * 2010-01-28 2013-02-04 Chemi Spa Nuovo polimorfo dell'estere 6-dietilamminometil-2-naftilico dell'acido 4-idrossicarbamoil-fenil-carbammico cloridrato.
US8217079B2 (en) * 2010-03-26 2012-07-10 Italfarmaco Spa Method for treating Philadelphia-negative myeloproliferative syndromes
WO2012120262A1 (en) 2011-03-09 2012-09-13 Larsson Pia Compounds and methods for improving impaired endogenous fibrinolysis using histone deacetylase inhibitors
BR112014018975A2 (pt) 2012-02-03 2018-05-08 Italfarmaco Spa Cloreto de dietil- [6-(4- hidroxicarbamoil-fenil- carbamoiloxi-metil) - naftalen- 2-il-metil] - amônio para uso no tratamento de distrofia muscular
ITUB20155193A1 (it) 2015-11-03 2017-05-03 Italfarmaco Spa Sospensioni orali di Givinostat fisicamente e chimicamente stabili
WO2018054960A1 (en) 2016-09-21 2018-03-29 INSERM (Institut National de la Santé et de la Recherche Médicale) Methods for predicting and treating resistance to chemotherapy in npm-alk(+) alcl
IT201900003281A1 (it) * 2019-03-06 2020-09-06 Chemi Spa Processo per preparare {6-[(dietilammino)metil]naftalen-2-il}metil [4-(idrossicarbamoil)fenil]carbammato ad elevata purezza

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2800498A (en) * 1954-09-12 1957-07-23 Lab Dausse Carbamates of dialkylaminoalkyl p-aminobenzoates
NO134946C (pt) * 1970-09-09 1977-01-12 Ciba Geigy Ag
US3804888A (en) * 1971-05-17 1974-04-16 Morton Norwich Products Inc 2-p-nitrobenzamidoacetohydroxamic acid
US3728380A (en) * 1971-05-17 1973-04-17 Morton Norwich Products Inc P-chlorobenzamidoacetohydroxamic acid
FR2354315A1 (fr) * 1976-06-10 1978-01-06 Eisai Co Ltd Nouveaux derives d'acide hydroxamique et medicaments en contenant
IL60888A (en) * 1978-06-16 1984-07-31 Yeda Res & Dev Substrates and process for the quantitative assay of enzymes
JPS5668650A (en) * 1979-11-07 1981-06-09 Otsuka Pharmaceut Co Ltd Benzoic acid amide derivative
GB8506870D0 (en) * 1985-03-16 1985-04-17 Wellcome Found Aryl derivatives
US4792560A (en) * 1985-04-03 1988-12-20 Rorer Pharmaceutical Corporation Quinoline hydroxamates and their use as modulators of arachidonic acid metabolic pathways
US4711900A (en) * 1986-07-23 1987-12-08 E. R. Squibb & Sons, Inc. Certain arylalkyl or pyridylalkyl hydroxamates useful for treating allergies and asthma
US4681894A (en) * 1986-09-26 1987-07-21 Ortho Pharmaceutical Corporation Hydroxamic acids and esters
US5280015A (en) * 1990-09-05 1994-01-18 The United States Of America As Represented By The Department Of Health And Human Services 2-substituted adenosines and 2-substituted adenosine 5'-carboxamides

Also Published As

Publication number Publication date
AU713300B2 (en) 1999-11-25
DK0901465T3 (da) 2000-12-18
DE69703207T2 (de) 2001-02-01
CZ366798A3 (cs) 1999-06-16
AU2896497A (en) 1997-12-05
BR9709234B1 (pt) 2009-01-13
BR9709234B8 (pt) 2014-04-15
US6034096A (en) 2000-03-07
CA2254066A1 (en) 1997-11-20
IT1283637B1 (it) 1998-04-23
CN1221403A (zh) 1999-06-30
EP0901465A1 (en) 1999-03-17
PL329873A1 (en) 1999-04-12
CN1105100C (zh) 2003-04-09
SK282174B6 (sk) 2001-11-06
RU2177473C2 (ru) 2001-12-27
ES2151267T3 (es) 2000-12-16
JP4108127B2 (ja) 2008-06-25
ITMI960968A1 (it) 1997-11-14
EP0901465B1 (en) 2000-09-27
JP2000510472A (ja) 2000-08-15
CZ293233B6 (cs) 2004-03-17
CA2254066C (en) 2007-09-11
PT901465E (pt) 2001-01-31
GR3035128T3 (en) 2001-04-30
WO1997043251A1 (en) 1997-11-20
ITMI960968A0 (pt) 1996-05-14
PL187527B1 (pl) 2004-07-30
DE69703207D1 (de) 2000-11-02
HU225650B1 (en) 2007-05-29
SK157998A3 (en) 1999-04-13
HUP9902818A3 (en) 2001-10-29

Similar Documents

Publication Publication Date Title
BR9709234A (pt) Composto com atividades antiinflamatórias e imunossupressivas
DE69738197D1 (de) Azolotriazine und pyrimidine
DE69710314D1 (de) Schallwandler mit mehreren elementen und gemeinsamer massenelektrode
DE69731341D1 (de) Optisches Bauelement und optisches System mit diesem
BR9711191A (pt) Composto e uso do mesmo
IT1288262B1 (it) Fresa bitagliente monoinserto ad elevata robustezza e precisione
NO990264L (no) Azolotriaziner og -pyrimidiner
PT950063E (pt) Construcoes peptidicas multirramificadas
PT819690E (pt) 6-tienil e 4-tienil pirimidinas herbicidas
DE69628756D1 (de) Kombinierte longitudinale und transversale Spurnachführung
ITMI942304A0 (it) Derivati fluorenil-idrossammici ad attivita' immunosoppressiva ed antiinfiammatoria
FI972010A0 (fi) Arrangemang i en borrningsanordning
KR970051241U (ko) 우산 겸용 파라솔
KR970063266U (ko) 음성 및 멜로디가 나오는 라이타
KR980001349U (ko) 승하강 개폐 칠판
KR980001350U (ko) 승하강 개폐 칠판
KR960017149U (ko) 우산겸용 파라솔이 장착된 자동차
IT242306Y1 (it) Termocamino con intercapedine e trombe
KR960026771U (ko) 화음을 내게한 팽이와 팽이채
FI974109A0 (fi) Arrangemang i en lindningsanordning
BR7603138U (pt) Prática e única
IT243038Y1 (it) Anello con struttura chiusa ed ampiezza regolabile
FI961432A0 (fi) Injekterings- och taetningsmassa
NO931735D0 (no) Bensin- og diesellaas
FR2754700B1 (fr) Assise de posturologie et de rachismetrie

Legal Events

Date Code Title Description
B07A Application suspended after technical examination (opinion) [chapter 7.1 patent gazette]
B06A Patent application procedure suspended [chapter 6.1 patent gazette]
B06A Patent application procedure suspended [chapter 6.1 patent gazette]
B09A Decision: intention to grant [chapter 9.1 patent gazette]
B16A Patent or certificate of addition of invention granted [chapter 16.1 patent gazette]

Free format text: PRAZO DE VALIDADE: 10 (DEZ) ANOS CONTADOS A PARTIR DE 13/01/2009, OBSERVADAS AS CONDICOES LEGAIS.

B22O Other matters related to patents and certificates of addition of invention: legal action concerning patent

Free format text: INPI-52400.061587/2013 ORIGEM: JUIZO DA 013A VARA FEDERAL DO RIO DE JANEIRO PROCESSO NO 0132263-70.2013.4.02.5101 ACAO DE NULIDADE DAS PATENTES SUBMETIDAS AO MAILBOX (ART. 229, PARAGRAFO UNICO DA LPI); ALTERNATIVAMENTE, A DECRETACAO DA NULIDADE PARCIAL PARA CORRECAO DO PRAZO DE VIGENCIA; SUBSIDIARIAMENTE, CASO SE ENTENDA NAO SER O CASO DE NULIDADE, A CORRECAO DO ATO ADMINISTRATIVO PARA ADEQUACAO DA VIGENCIA DAS PATENTES. AUTOR: INSTITUTO NACIONAL DA PROPRIEDADE INDUSTRIAL - INPI REU: GILEAD SCIENCES, INC, HRISSANTHI IKONOMIDOU, INNOGENETICS N.V., ISTITUTO NAZIONALE PRE LO STUDIO E LA, CURA DEI TUMORI, ITALFARMACO S.P.A.

B19A Notification of judicial decision: notification of judicial decision

Free format text: INPI-0132263-70.2013.4.02.5101 SECAO JUDICIARIA DO RIO DE JANEIRO-13A VARA FEDERAL DO RIO DE JANEIRO PROCESSO NO52400.061587/2013-47 AUTOR:INPI-INSTITUTO NACIONAL DE PROPRIEDADE INDUSTRIAL REU(S):GILEAD SCIENCES INC.,HRISSANTHI IKONOMIDOU, INNOGENTICS NV, ISTITUTO NAZIONALE PER LO STUDIO E LA CURA DEI TUMORI E ITALFARMACO SPA DECISAO:HOMOLOGO O ACORDO FIRMADO PELAS PARTES JULGANDO EXTINTO O PROCESSO COM RESOLUCAO DE MERITO, FORTE NO ART.269, III DO CODIGO DE PROCESSO CIVIL.

B16C Correction of notification of the grant [chapter 16.3 patent gazette]

Free format text: RETICADA A PUBLICACAO DA CONCESSAO DA CARTA PATENTE EXPEDIDA NA RPI 1984 DE 13/01/2009, CONFORME DECISAO JUDICIAL DA 13A VARA FEDERAL DO RIO DE JANEIRO, CORRIGINDO O PRAZO DE VIGENCIA DA REFERIDA PATENTE PARA 12/05/2017

B21A Patent or certificate of addition expired [chapter 21.1 patent gazette]

Free format text: PATENTE EXTINTA EM 12.05.2017